NSE filing, NSE: BALAJIPHOS. Summary written from the filing by ALFA Finder's alert engine.
Balaji Phosphates Ltd: key numbers
- Share price
- ₹104.95
- Market cap
- ₹249.5 Cr
- Revenue (annual)
- ₹170.5 Cr
- Net profit (annual)
- ₹10.22 Cr
- P/E (TTM)
- 24.4×Sector 9.7×
- Promoter holding
- 69.90%
- FII holding
- 1.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Balaji Phosphates Ltd
All →Balaji Phosphates Other Announcement
Balaji Phosphates Limited has informed regarding the non-applicability of corporate governance provisions for the quarter ended 30th September, 2026, due to its SME listing status.
Balaji Phosphates Fund Raise of ₹23.45 Cr
Balaji Phosphates received shareholder approval to issue 25,00,000 convertible warrants worth ₹23.45 Crore and 14,49,900 equity shares for a business acquisition via preferential issue.
- Value
- ₹23.45 Cr
Balaji Phosphates Capital Structure Change
Balaji Phosphates' shareholders approved the issuance of 5,146,350 convertible warrants and 1,449,900 equity shares to promoters and other investors at the 30th AGM.
Balaji Phosphates Annual General Meeting
Balaji Phosphates Limited issued a corrigendum to its 30th Annual General Meeting notice. The amendment provides revisions to the proposed preferential share allotment for business acquisition.
Balaji Phosphates Board Meeting Outcome
Balaji Phosphates Limited replaced an allottee for its proposed 25 lakh warrant issuance. The board also approved a corrigendum to its AGM notice per NSE observations.
- Value
- ₹23.45 Cr
Balaji Phosphates Board Meeting Date
Balaji Phosphates Limited scheduled a board meeting for September 18, 2026, to discuss fund raising via preferential issue.
Other board meeting date announcements
All →M & B Engineering Board Meeting Date
M&B Engineering schedules a board meeting on 5 Nov 2026 to consider and approve unaudited financial results for Q1 and H1 FY27. No results or financial figures are disclosed in this intimation.
Allcargo Terminals Board Meeting Date
Allcargo Terminals scheduled a board meeting for 4 Nov 2026 to approve Q1/H1 FY27 financial results. The trading window remains closed until 6 Nov 2026.
Gillanders Arbuthnot & Company Board Meeting Date
Gillanders Arbuthnot scheduled its board meeting for 13 November 2026 to approve Q2/H1 FY27 results. No decisions or figures have been announced yet.
Windlas Biotech Board Meeting Date
Windlas Biotech intimated that its Board meeting is scheduled for 5 November 2026 to consider unaudited standalone results for Q1 FY27. No monetary figure is disclosed in this advance notice.
TARC Board Meeting Date
TARC Ltd intimated that its Board will meet on 5 Nov 2026. The agenda includes approving unaudited H1 FY27 financial results.
Shiva Mills Board Meeting Date
Shiva Mills has scheduled its Board meeting for 12 November 2026 to approve unaudited financial results for the quarter and six months ended 30 September 2026.